To access this element change to forms mode OFF

Grant Award View - GA30130

GNT1162860 | "Fine-tuned" manipulation of the c-MET oncogenic pathway in...

Contact Details

NHMRC Research Help Centre

Phone:
1800 500 983

Email Address:

GA ID:
GA30130
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$707,521.00 (GST inclusive where applicable)

Ad hoc/One-off:
No
Aggregate Grant Award:
No

PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
GNT1162860 | "Fine-tuned" manipulation of the c-MET oncogenic pathway in pancreatic cancer: a new paradigm of personalised medicine.
Purpose:
Only 8 percent of patients with pancreatic cancer (PC) survive the disease, and current therapies, tested in all-comers, have limited success. More than a third of patients with PC may benefit from a novel combination therapy of agents that target cancer cell growth and survival. Significance of our work lies in identifying treatment strategies that can be directed to PC patients in a subgroup-selective manner, ultimately leading to reductions in the mortality associated with this lethal cancer.

GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
2018 Project Grant funding commencing 2019
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
Garvan Institute of Medical Research
Recipient ABN:
62 330 391 937

Grant Recipient Location

Suburb:
Darlinghurst
Town/City:
Darlinghurst
Postcode:
2010
State/Territory:
NSW
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
NSW
Country:
AUSTRALIA

Contact Details

NHMRC Research Help Centre

Phone:
1800 500 983

Email Address: